NCT03610412View on ClinicalTrials.gov

Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

November 24, 2020

Study Completion Date

August 18, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

Cinnamomum Cassia

The intervention period will be 90 days, unlike other trials with Cinnamomum cassia and the main effect sought is on IGF1 levels, in addition to metabolic control.

OTHER

Placebo (calcined magnesia)

The intervention period will be 90 days, unlike other trials with Cinnamomum cassia and comparison with placebo. The main effect sought is on IGF1 levels, in addition to metabolic control.

Trial Locations (1)

44380

Biomedical Unit Research 02, Specialties Hospital, Medical Unit of High Specialty, West National Medical Center, Mexican Social Security Institute., Guadalajara

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT03610412 - Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated | Biotech Hunter | Biotech Hunter